Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a delphi process

Gastroenterology

Volumn 143, Issue 2, 2012, Pages 336-346

  Bennett, Cathy ^a   Vakil, Nimish ^b   Bergman, Jacques ^c   Harrison, Rebecca ^d   Odze, Robert ^e   Vieth, Michael ^f   Sanders, Scott ^g   Gay, Laura ^h   Pech, Oliver ^f   Longcroft Wheaton, Gaius ⁱ   Romero, Yvonne ^j   Inadomi, John ^k   Tack, Jan ^l   Corley, Douglas A ^m   Manner, Hendrik ⁿ   Green, Susi ⁱ   Al Dulaimi, David ^o   Ali, Haythem ^p   Allum, Bill ^q   Anderson, Mark ^r,bq   Curtis, Howard ^s   Falk, Gary ^t   Fennerty, M Brian ^u   Fullarton, Grant ^v   Krishnadath, Kausilia ^c   Meltzer, Stephen J ^w   Armstrong, David ^x   Ganz, Robert ^y   Cengia, Gianpaolo ^z   Going, James J ^v   Goldblum, John ^aa   Gordon, Charles ^ab   Grabsch, Heike ^ad   Haigh, Chris ^ae   Hongo, Michio ^af   Johnston, David ^ag   Forbes Young, Ricky ^ah   Kay, Elaine ^ai   Kaye, Philip ^aj   Lerut, Toni ^l   Lovat, Laurence B ^ak   Lundell, Lars ^al   Mairs, Philip ^am   Shimoda, Tadakuza ^an   Spechler, Stuart ^ao   Sontag, Stephen ^ap   Malfertheiner, Peter ^aq   Murray, Iain ^ar   Nanji, Manoj ^h   Poller, David ⁱ   Ragunath, Krish ^aj   Regula, Jaroslaw ^as   Cestari, Renzo ^z   Shepherd, Neil ^at   Singh, Rajvinder ^au   Stein, Hubert J ^av   Talley, Nicholas J ^aw   Galmiche, Jean Paul ^ax   Tham, Tony C K ^ay   Watson, Peter ^a   Yerian, Lisa ^aa   Rugge, Massimo ^ac   Rice, Thomas W ^aa   Hart, John ^az   Gittens, Stuart ^ba   Hewin, David ^at   Hochberger, Juergen ^bb   Kahrilas, Peter ^bc   Preston, Sean ^bd   Sampliner, Richard ^be   Sharma, Prateek ^bf   Stuart, Robert ^bg   Wang, Kenneth ^j   Waxman, Irving ^az   Abley, Chris ^d   Loft, Duncan ^bh   Penman, Ian ^ah   Shaheen, Nicholas J ^bi   Chak, Amitabh ^bj   Davies, Gareth ^bk   Dunn, Lorna ^bl   Falck Ytter, Yngve ^bm   Decaestecker, John ^d   Bhandari, Pradeep ⁱ   Ell, Christian ^f   Griffin, S Michael ^bl   Attwood, Stephen ^bn   Barr, Hugh ^at   Allen, John ^bo   Ferguson, Mark K ^az   Moayyedi, Paul ^x   Jankowski, Janusz A Z ^d,h,bp   more..

^a QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c ACADEMIC MEDICAL CENTER   (Netherlands)

^d UNIVERSITY HOSPITALS OF LEICESTER NHS TRUST   (United Kingdom)

^e HARVARD MEDICAL SCHOOL   (United States)

^f INSTITUTE OF PATHOLOGY   (Germany)

^g UNIVERSITY OF WARWICK   (United Kingdom)

^h QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁱ QUEEN ALEXANDRA HOSPITAL   (United Kingdom)

^j MAYO CLINIC   (United States)

^k UNIVERSITY OF WASHINGTON   (United States)

^l UNIVERSITY OF LEUVEN   (Belgium)

^m KAISER PERMANENTE   (United States)

ⁿ HSK Hospital   (Germany)

^o Redditch General Hospital   (United Kingdom)

^p MAIDSTONE AND TUNBRIDGE WELLS NHS TRUST   (United Kingdom)

^q ROYAL MARSDEN HOSPITAL   (United Kingdom)

^r CITY HOSPITAL   (United Kingdom)

^s QUEEN MARY S HOSPITAL   (United Kingdom)

^t UNIVERSITY OF PENNSYLVANIA   (United States)

^u OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^v GLASGOW ROYAL INFIRMARY   (United Kingdom)

^w JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^x MCMASTER UNIVERSITY   (Canada)

^y Bloomington Medical Centre   (United States)

^z UNIVERSITY OF BRESCIA   (Italy)

^aa LERNER RESEARCH INSTITUTE   (United States)

^ab ROYAL BOURNEMOUTH HOSPITAL   (United Kingdom)

^ac UNIVERSITY OF PADOVA   (Italy)

^ad UNIVERSITY OF LEEDS   (United Kingdom)

^ae WANSBECK GENERAL HOSPITAL   (United Kingdom)

^af TOHOKU UNIVERSITY HOSPITAL   (Japan)

^ag NINEWELLS HOSPITAL   (United Kingdom)

^ah ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^ai TRINITY COLLEGE DUBLIN   (Ireland)

^aj NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^ak UNIVERSITY COLLEGE LONDON   (United Kingdom)

^al KAROLINSKA INSTITUTE   (Sweden)

^am DARENT VALLEY HOSPITAL   (United Kingdom)

^an NATIONAL CANCER CENTER   (Japan)

^ao UNIVERSITY OF DALLAS   (United States)

^ap HINES VA HOSPITAL   (United States)

^aq OTTO VON GUERICKE UNIVERSITY   (Germany)

^ar ROYAL CORNWALL HOSPITAL   (United Kingdom)

^as INSTITUTE OF ONCOLOGY   (Poland)

^at GLOUCESTERSHIRE ROYAL HOSPITAL   (United Kingdom)

^au UNIVERSITY OF ADELAIDE   (Australia)

^av Heart Center Bogenhausen   (Germany)

^aw UNIVERSITY OF NEWCASTLE   (Australia)

^ax NANTES UNIVERSITY HOSPITAL   (France)

^ay ULSTER HOSPITAL   (United Kingdom)

^az UNIVERSITY OF CHICAGO   (United States)

^ba ECD Solutions   (Barbados)

^bb St Bernward Hospital   (Germany)

^bc NORTHWESTERN UNIVERSITY   (United States)

^bd BARTS HEALTH NHS TRUST   (United Kingdom)

^be UNIVERSITY OF ARIZONA   (United States)

^bf UNIVERSITY OF KANSAS   (United States)

^bg Oesophageal Cancer Fund   (Ireland)

^bh WALSGRAVE HOSPITAL   (United Kingdom)

^bi UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^bj CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^bk HARROGATE DISTRICT HOSPITAL   (United Kingdom)

^bl ROYAL VICTORIA INFIRMARY   (United Kingdom)

^bm Louis Stokes Medical Center   (United States)

^bn DURHAM UNIVERSITY   (United Kingdom)

^bo UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^bp UNIVERSITY OF OXFORD   (United Kingdom)

^bq SANDWELL GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

BADCAT; Esophageal Cancer; Systematic Analysis; Treatment Strategy

Indexed keywords

ARTICLE; BARRETT ESOPHAGUS; CANCER RADIOTHERAPY; CANCER STAGING; CONSENSUS; CONTROLLED STUDY; DISEASE CLASSIFICATION; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS DYSPLASIA; ESOPHAGUS RESECTION; EVIDENCE BASED MEDICINE; FOLLOW UP; HIGH GRADE DYSPLASIA; HUMAN; HUMAN TISSUE; LOW GRADE DYSPLASIA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION;

EID: 84864192459     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2012.04.032     Document Type: Article

References (124)

1. N.J. Vakil, S.V. van Zanten, P. Kahrilas The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus Am J Gastroenterol 101 2006 1900 1920
2. A.C. Ford, D. Forman, P.D. Reynolds Ethnicity, gender, and socioeconomic status as risk factors for esophagitis and Barrett's esophagus Am J Epidemiol 162 2005 454 460 (Pubitemid 41191431)
3. J.B. Taylor, J.H. Rubenstein Meta-analyses of the effect of symptoms of gastroesophageal reflux on the risk of Barrett's esophagus Am J Gastroenterol 105 2010 1730 1737
4. J. Ronkainen, N.J. Talley, T. Storskrubb Erosive esophagitis is a risk factor for Barrett's esophagus: a community-based endoscopic follow-up study Am J Gastroenterol 106 2011 1946 1952
5. P. Moayyedi, A.T. Axon Review article: gastro-esophageal reflux disease - the extent of the problem Aliment Pharmacol Ther 22 Suppl 1 2005 11 19 (Pubitemid 41153075)
6. National Cancer Institute Fast stats: esophagus cancer http://seer.cancer.gov/faststats/selections.php 2008 Accessed May 15, 2011
7. K.W. Jung, N.J. Talley, Y. Romero Epidemiology and natural history of intestinal metaplasia of the gastroesophageal junction and Barrett's esophagus: a population-based study Am J Gastroenterol 106 2011 1447 1455
8. F. Hvid-Jensen, L. Pedersen, A.M. Drewes Incidence of adenocarcinoma among patients with Barrett's esophagus N Engl J Med 365 2011 1375 1383
9. M. Solaymani-Dodaran, R.F. Logan, J. West Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux Gut 53 2004 1070 1074 (Pubitemid 38961957)
10. S.J. Spechler, P. Sharma, R.F. Souza American Gastroenterological Association medical position statement on the management of Barrett's esophagus Gastroenterology 140 2011 1084 1091
11. K. Wang, R. Sampliner Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus Am J Gastroenterol 103 2008 788 797 (Pubitemid 351406009)
12. S.J. Spechler, P. Sharma, R.F. Souza American Gastroenterological Association technical review on the management of Barrett's esophagus Gastroenterology 140 2011 e18 e52
13. G.A. Prasad, A. Bansal, P. Sharma Predictors of progression in Barrett's esophagus: current knowledge and future directions Am J Gastroenterol 105 2010 1490 1502
14. S.J. Spechler Barrett's esophagus: clinical issues Gastrointest Endosc Clin N Am 21 2011 1 7
15. J. Dent Barrett's esophagus: a historical perspective, an update on core practicalities and predictions on future evolutions of management J Gastroenterol Hepatol 26 Suppl 1 2011 11 30
16. C. Evans The use of consensus methods and expert panels in pharmacoeconomic studies Practical applications and methodological shortcomings Pharmacoeconomics 12 1997 121 129 (Pubitemid 27323221)
17. C. Powell The Delphi technique: myths and realities J Adv Nurs 41 2003 376 382 (Pubitemid 37255969)
18. M.K. Murphy, N.A. Black, D.L. Lamping Consensus development methods, and their use in clinical guideline development Health Technol Assess 2 3 1998
19. H.J. Schunemann, D. Best, G. Vist Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations CMAJ 169 2003 677 680 (Pubitemid 37266979)
20. G. Guyatt, D. Gutterman, M.H. Baumann Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force Chest 129 2006 174 181 (Pubitemid 43265259)
21. N.J. Talley, M.T. Abreu, J.P. Achkar An evidence-based systematic review on medical therapies in inflammatory bowel disease Am J Gastroenterol 106 Supp 1 2011 S2 S25
22. R.J. Schlemper, R.H. Riddell, Y. Kato Vienna classification of gastrointestinal epithelial neoplasia Gut 47 2000 251 255 (Pubitemid 30489769)
23. A.H. Ormsby, R.E. Petras, W.H. Henricks Observer variation in the diagnosis of superficial oesophageal adenocarcinoma Gut 51 2002 671 676 (Pubitemid 35216854)
24. E. Montgomery, M.P. Bronner, J.R. Goldblum Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation Hum Pathol 32 2001 368 378 (Pubitemid 32378298)
25. E. Downs-Kelly, J.E. Mendelin, A.E. Bennett Poor interobserver agreement in the distinction of high-grade dysplasia and adenocarcinoma in pretreatment Barrett's esophagus biopsies Am J Gastroenterol 103 2008 2333 2340
26. B.J. Reid, R.C. Haggitt, C.E. Rubin Observer variation in the diagnosis of dysplasia in Barrett's esophagus Hum Pathol 19 1988 166 178 (Pubitemid 18091022)
27. M. Skacel, R.E. Petras, T.L. Gramlich The diagnosis of low grade dysplasia in Barrett's esophagus and its implication for disease progression Am J Gastroenterol 95 2000 3383 3387
28. E. Montgomery, J.R. Goldblum, J.K. Greenson Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study Hum Pathol 32 2001 379 388 (Pubitemid 32378299)
29. P.V. Kaye, S.A. Haider, M. Ilyas Barrett's dysplasia and the Vienna classification: reproducibility, prediction of progression and impact of consensus reporting and p53 immunohistochemistry Histopathology 54 2009 699 712
30. W. Curvers, F. ten Kate, K. Krishnadath Low-grade dysplasia in Barrett's esophagus: overdiagnosed and underestimated Am J Gastroenterol 105 2010 1523 1530
31. R.H. Riddell, R.D. Odze Definition of Barrett's esophagus: time for a rethink-is intestinal metaplasia dead? Am J Gastroenterol 104 2009 2588 2594
32. P. Chaves, M. Crespo, C. Ribeiro Chromosomal analysis of Barrett's cells: demonstration of instability and detection of the metaplastic lineage involved Mod Pathol 20 2007 788 796 (Pubitemid 46933442)
33. S. Romagnoli, M. Roncalli, D. Graziani Molecular alterations of Barrett's esophagus on microdissected endoscopic biopsies Lab Invest 81 2001 241 247 (Pubitemid 32176388)
34. W. Liu, H. Hahn, R.D. Odze Metaplastic esophageal columnar epithelium without goblet cells shows DNA content abnormalities similar to goblet cell containing epithelium Am J Gastroenterol 104 2009 816 824
35. C.J. Kelty, M.D. Gough, Q. Van Wyk Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk Scand J Gastroenterol 42 2007 1271 1274 (Pubitemid 47537076)
36. P.A. Gatenby, J.R. Ramus, C.P. Caygill Relevance of the detection of intestinal metaplasia in non-dysplastic columnar-lined oesophagus Scand J Gastroenterol 43 2008 524 530 (Pubitemid 351536041)
37. A. Srivastava, J.L. Hornick, X. Li Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus Am J Gastroenterol 102 2007 483 493 (Pubitemid 46328161)
38. N.S. Buttar, K.K. Wang, T.J. Sebo Extent of high-grade dysplasia in Barrett's esophagus correlates with risk of adenocarcinoma Gastroenterology 120 2001 1630 1639 (Pubitemid 32523482)
39. M.S. Dar, J.R. Goldblum, T.W. Rice Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? Gut 52 2003 486 489 (Pubitemid 36363397)
40. O. Pech, A. Behrens, A. May Long-term results and risk factor analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett's oesophagus Gut 57 2008 1200 1206
41. O. Pech, L. Gossner, H. Manner Prospective evaluation of the macroscopic types and location of early Barrett's neoplasia in 380 lesions Endoscopy 39 2007 588 593 (Pubitemid 47098994)
42. F.P. Peters, K.P. Brakenhoff, W.L. Curvers Histologic evaluation of resection specimens obtained at 293 endoscopic resections in Barrett's esophagus Gastrointest Endosc 67 2008 604 609
43. C. Tharavej, J.A. Hagen, J.H. Peters Predictive factors of coexisting cancer in Barrett's high-grade dysplasia Surg Endosc 20 2006 439 443 (Pubitemid 43260503)
44. A. Rastogi, S. Puli, H.B. El-Serag Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: a meta-analysis Gastrointest Endosc 67 2008 394 398 (Pubitemid 351260043)
45. T.G. Schnell, S.J. Sontag, G. Chejfec Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia Gastroenterology 120 2001 1607 1619 (Pubitemid 32523480)
46. B.F. Overholt, C.J. Lightdale, K.K. Wang Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial Gastrointest Endosc 62 2005 488 498 (Pubitemid 41383764)
47. B.J. Reid, D.S. Levine, G. Longton Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets Am J Gastroenterol 95 2000 1669 1676 (Pubitemid 30485000)
48. A.P. Weston, P. Sharma, M. Topalovski Long-term follow-up of Barrett's high-grade dysplasia Am J Gastroenterol 95 2000 1888 1893
49. N.J. Shaheen, P. Sharma, B.F. Overholt Radiofrequency ablation in Barrett's esophagus with dysplasia N Engl J Med 360 2009 2277 2288
50. S. Wani, S.R. Puli, N.J. Shaheen Esophageal adenocarcinoma in Barrett's esophagus after endoscopic ablative therapy: a meta-analysis and systematic review Am J Gastroenterol 104 2009 502 513
51. V.S. Wang, J.L. Hornick, J.A. Sepulveda Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience Gastrointest Endosc 69 2009 777 783
52. H.C. Wolfsen, J.E. Crook, M. Krishna Prospective, controlled tandem endoscopy study of narrow band imaging for dysplasia detection in Barrett's Esophagus Gastroenterology 135 2008 24 31 (Pubitemid 351899007)
53. J. Pohl, A. May, T. Rabenstein Comparison of computed virtual chromoendoscopy and conventional chromoendoscopy with acetic acid for detection of neoplasia in Barrett's esophagus Endoscopy 39 2007 594 598 (Pubitemid 47098995)
54. G. Longcroft-Wheaton, M. Duku, R. Mead Acetic acid spray is an effective tool for the endoscopic detection of neoplasia in patients with Barrett's esophagus Clin Gastroenterol Hepatol 8 2010 843 847
55. F.P. Peters, W.L. Curvers, W.D. Rosmolen Surveillance history of endoscopically treated patients with early Barrett's neoplasia: nonadherence to the Seattle biopsy protocol leads to sampling error Dis Esophagus 21 2008 475 479
56. R. Kariv, T.P. Plesec, J.R. Goldblum The Seattle protocol does not more reliably predict the detection of cancer at the time of esophagectomy than a less intensive surveillance protocol Clin Gastroenterol Hepatol 7 2009 653 658
57. F.P. Peters, M.A. Kara, W.D. Rosmolen Endoscopic treatment of high-grade dysplasia and early stage cancer in Barrett's esophagus Gastrointest Endosc 61 2005 506 514 (Pubitemid 40462188)
58. C. Ell, A. May, O. Pech Curative endoscopic resection of early esophageal adenocarcinomas (Barrett's cancer) Gastrointest Endosc 65 2007 3 10 (Pubitemid 44932158)
59. R.E. Pouw, K. Wirths, P. Eisendrath Efficacy of radiofrequency ablation combined with endoscopic resection for Barrett's esophagus with early neoplasia Clin Gastroenterol Hepatol 8 2010 23 29
60. R.E. Pouw, S. Seewald, J.J. Gondrie Stepwise radical endoscopic resection for eradication of Barrett's oesophagus with early neoplasia in a cohort of 169 patients Gut 59 2010 1169 1177
61. M.J. Hull, M. Mino-Kenudson, N.S. Nishioka Endoscopic mucosal resection: an improved diagnostic procedure for early gastroesophageal epithelial neoplasms Am J Surg Pathol 30 2006 114 118 (Pubitemid 43740217)
62. M. Mino-Kenudson, M.J. Hull, I. Brown EMR for Barrett's esophagus-related superficial neoplasms offers better diagnostic reproducibility than mucosal biopsy Gastrointest Endosc 66 2007 660 666 (Pubitemid 47495911)
63. A. Moss, M.J. Bourke, L.F. Hourigan Endoscopic resection for Barrett's high-grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long-term therapeutic benefit Am J Gastroenterol 105 2010 1276 1283
64. W.L. Curvers, R. Singh, L.M. Song Endoscopic tri-modal imaging for detection of early neoplasia in Barrett's oesophagus: a multi-centre feasibility study using high-resolution endoscopy, autofluorescence imaging and narrow band imaging incorporated in one endoscopy system Gut 157 2008 67 172
65. H.J. Stein, M. Feith, B.L.D.M. Bruecher Early esophageal squamous cell and adenocarcinoma: pattern of lymphatic spread and prognostic factors for long term survival after surgical resection Ann Surg 242 2005 566 573
66. E. Bollschweiler, S.E. Baldus, W. Schröder High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas Endoscopy 38 2006 149 156 (Pubitemid 43286392)
67. O. Pech, A. May, E. Gunter The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus Am J Gastroenterol 101 2006 2223 2229 (Pubitemid 44477547)
68. O. Pech, E. Günter, F. Dusemund Value of high-frequency miniprobes and conventional radial endoscopic ultrasound in the staging of early Barrett's carcinoma Endoscopy 42 2010 98 103
69. M. Vieth, C. Ell, L. Gossner Histological analysis of endoscopic resection specimens from 326 patients with Barrett's esophagus and early neoplasia Endoscopy 36 2004 776 781 (Pubitemid 39207150)
70. M. Westerterp, L.B. Koppert, C.J. Buskens Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction Virchows Arch 446 2005 497 504 (Pubitemid 40884282)
71. G.A. Prasad, T.T. Wu, D.A. Wigle Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett's esophagus Gastroenterology 137 2009 815 823
72. R.J. Badreddine, G.A. Prasad, K.K. Wang Prevalence and predictors of recurrent neoplasia after ablation of Barrett's esophagus Gastrointest Endosc 71 2010 697 703
73. C.V. Lopes, M. Hela, C. Pesenti Circumferential endoscopic resection of Barrett's esophagus with high-grade dysplasia or early adenocarcinoma Surg Endosc 21 2007 820 824 (Pubitemid 46675513)
74. M. Giovannini, E. Bories, C. Pesenti Circumferential endoscopic mucosal resection in Barrett's esophagus with high-grade intraepithelial neoplasia or mucosal cancer Preliminary results in 21 patients Endoscopy 36 2004 782 787 (Pubitemid 39207151)
75. S. Seewald, T. Akaraviputh, U. Seitz Circumferential EMR and complete removal of Barrett's epithelium: a new approach to management of Barrett's esophagus containing high-grade intraepithelial neoplasia and intramucosal carcinoma Gastrointest Endosc 57 2003 854 859 (Pubitemid 47241100)
76. R. Metzger, E. Bollschweiler, D. Vallbohmer High volume centers for esophagectomy: what is the number needed to achieve low postoperative mortality? Dis Esophagus 17 2004 310 314 (Pubitemid 40123807)
77. P.A. Testoni, A. Mariani, A. Giussani SEIFRED Group Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study Am J Gastroenterol 105 2010 1753 1761
78. J.J. Bergman Radiofrequency ablation - great for some or justified for many? N Engl J Med 360 2009 2353 2355
79. O. Pech, C. Ell Endoscopic therapy of Barrett's esophagus Curr Opin Gastroenterol 25 2009 405 411
80. O. Pech, A. May, T. Rabenstein Endoscopic resection of early oesophageal cancer Gut 56 2007 1625 1634 (Pubitemid 350033204)
81. R.E. Pouw, J.J. Bergman Endoscopic resection of early oesophageal and gastric neoplasia Best Pract Res Clin Gastroenterol 22 2008 929 943
82. R.E. Pouw, V.K. Sharma, J.J. Bergman Radiofrequency ablation for total Barrett's eradication: a description of the endoscopic technique, its clinical results and future prospects Endoscopy 40 2008 1033 1040
83. A. May, L. Gossner, O. Pech Local endoscopic therapy for intraepithelial high-grade neoplasia and early adenocarcinoma in Barrett's oesophagus: acute-phase and intermediate results of a new treatment approach Eur J Gastroenterol Hepatol 14 2002 1085 1091 (Pubitemid 35178769)
84. J.J. Gondrie, R.E. Pouw, C.M. Sondermeijer Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients Endoscopy 40 2008 359 369 (Pubitemid 351696372)
85. J.J. Gondrie, R.E. Pouw, C.M. Sondermeijer Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system Endoscopy 40 2008 370 379 (Pubitemid 351696373)
86. D. Fayter, M. Corbett, M. Heirs A systematic review of photodynamic therapy in the treatment of pre-cancerous skin conditions, Barrett's oesophagus and cancers of the biliary tract, brain, head and neck, lung, oesophagus and skin Health Technol Assess 14 2010 1 288
87. B.F. Overholt, K.K. Wang, J.S. Burdick International Photodynamic Group for High-Grade Dysplasia in Barrett's Esophagus Five-year efficacy and safety of photodynamic therapy with Photofrin in Barrett's high-grade dysplasia Gastrointest Endosc 66 2007 460 468 (Pubitemid 47304412)
88. M. Hage, P.D. Siersema, H. van Dekken 5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial Gut 53 2004 785 790 (Pubitemid 38662126)
89. Y.M. Li, L. Li, C.H. Yu A systematic review and meta-analysis of the treatment for Barrett's esophagus Digest Dis Sci 53 2008 2837 2846
90. T. Semlitsch, K. Jeitler, R. Schoefl A systematic review of the evidence for radiofrequency ablation for Barrett's esophagus Surg Endosc 24 2010 2935 2943
91. D.E. Fleischer, B.F. Overholt, V.K. Sharma Endoscopic radiofrequency ablation for Barrett's esophagus: 5-year outcomes from a prospective multicenter trial Endoscopy 42 2010 781 789
92. H. Beaumont, J.J. Gondrie, B.P. McMahon Stepwise radiofrequency ablation of Barrett's esophagus preserves esophageal inner diameter, compliance, and motility Endoscopy 41 2009 2 8
93. R.E. Pouw, J.J. Gondrie, A.M. Rygiel Properties of the neosquamous epithelium after radiofrequency ablation of Barrett's esophagus containing neoplasia Am J Gastroenterol 104 2009 1366 1373
94. T. Gotoda, A. Yanagisawa, M. Sasako Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers Gastric Cancer 3 2000 219 225 (Pubitemid 32290729)
95. H. Manner, A. May, O. Pech Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent Am J Gastroenterol 103 2008 2589 2597
96. D. Menon, T. Stafinski, H. Wu Endoscopic treatments for Barrett's esophagus: a systematic review of safety and effectiveness compared to esophagectomy BMC Gastroenterol 10 2010 111
97. S.R. DeMeester Evaluation and treatment of superficial esophageal cancer J Gastrointest Surg 14 Suppl 1 2010 S94 S100
98. G.A. Prasad, K.K. Wang, N.S. Buttar Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus Gastroenterology 132 2007 1226 1233 (Pubitemid 46627583)
99. J.D. McAllaster, D. Buckles, M. Al-Kasspooles Treatment of Barrett's esophagus with high-grade dysplasia Expert Rev Anticancer Ther 9 2009 303 316
100. N.K. Altorki, P.C. Lee, Y. Liss Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment Ann Surg 247 2008 434 439
101. E.E. Tseng, T.T. Wu, C.J. Yeo Barrett's esophagus with high grade dysplasia: surgical results and long-term outcome-an update J Gastrointest Surg 7 2003 164 170
102. M.F. Reed, G. Tolis Jr, B.H. Edil Surgical treatment of esophageal high-grade dysplasia Ann Thorac Surg 79 2005 1110 1115 (Pubitemid 40431823)
103. L.C. Chang, B.K. Oelschlager, E. Quiroga Long-term outcome of esophagectomy for high-grade dysplasia or cancer found during surveillance for Barrett's esophagus J Gastrointest Surg 10 2006 341 346 (Pubitemid 43303827)
104. T.W. Rice Pro: esophagectomy is the treatment of choice for high-grade dysplasia in Barrett's esophagus Am J Gastroenterol 101 2006 2177 2179
105. R.J. Moraca, D.E. Low Outcomes and health-related quality of life after esophagectomy for high-grade dysplasia and intramucosal cancer Arch Surg 141 2006 545 549
106. C.G. Peyre, S.R. DeMeester, C. Rizzetto Vagal-sparing esophagectomy: the ideal operation for intramucosal adenocarcinoma and Barrett with high-grade dysplasia Ann Surg 246 2007 665 671 (Pubitemid 47480620)
107. V.A. Williams, T.J. Watson, F.A. Herbella Esophagectomy for high grade dysplasia is safe, curative, and results in good alimentary outcome J Gastrointest Surg 11 2007 1589 1597
108. R. Mirnezami, A. Rohatgi, R.P. Sutcliffe Transhiataloesophagectomy: treatment of choice for high-grade dysplasia Eur J Cardiothorac Surg 36 2009 364 367
109. D.N. Sutton, J. Wayman, S.M. Griffin Learning curve for oesophagealcanver surgery Br J Surg 85 1998 1399 1402
110. C.B. Begg, L.D. Cramer, W.J. Hoskins Impact of hospital volume on operative mortality for major cancer surgery JAMA 280 1998 1747 1751 (Pubitemid 28536874)
111. J. Wenner, T. Zilling, A. Bladstrom The influence of surgical volume on hospital mortality and 5-year survival for carcinoma of the oesophagus and gastric cardia Anticancer Res 25 2005 419 424 (Pubitemid 40470044)
112. M.W. Wouters, H.E. Karim-Kos, S. Le Cessie Centralization of esophageal cancer surgery: does it improve clinical outcome? Ann Surg Oncol 16 2009 1789 1798
113. R.J. Skipworth, R.W. Parks, N.A. Stephens The relationship between hospital volume and post-operative mortality rates for upper gastrointestinal cancer resections: Scotland 1982-2003 Eur J Surg Oncol 36 2010 141 147
114. S.R. Hamilton, J.H. Yardley Regenerative of cardiac type mucosa and acquisition of Barrett mucosa after esophagogastrostomy Gastroenterology 72 1977 669 675 (Pubitemid 8097609)
115. S.M. Dresner, S.M. Griffin, J. Wayman Human model of duodenogastro- oesophageal reflux in the development of Barrett's metaplasia Br J Surg 90 2003 1120 1128 (Pubitemid 37152171)
116. A. Watson, R.C. Heading, N.A. Shepherd Guidelines for the diagnosis and management of Barrett's columnar-lined oesophagus A Report of the Gastroenterology Working Party of the British Society of Gastroenterology http://www.bsg.org.uk/clinical-guidelines/oesophageal/guidelines-for-the- diagnosis-and-management-of-barrett-s-columnar-lined-oesophagus.html August 2005 Accessed May 4, 2010
117. A. Nicholson, J. Jankowski Editorial: one small step for metaplasia, but one giant leap for biomarkers is needed Am J Gastroenterol 104 2009 2681 2683
118. J. Cronin, E. McAdam, A. Danikas Epidermal growth factor receptor (EGFR) is overexpressed in high-grade dysplasia and adenocarcinoma of the esophagus and may represent a biomarker of histological progression in Barrett's esophagus (BE) Am J Gastroenterol 106 2011 46 56
119. S. Wani, G.W. Falk, J. Post Risk factors for progression of low-grade dysplasia in patients with Barrett's esophagus Gastroenterology 141 2011 1179 1186
120. M. Sikkema, C.W.N. Looman, E.W. Steyerberg Predictors for neoplastic progression in patients with Barrett 's esophagus: a prospective cohort study Am J Gastroenterol 106 2011 1231 1238
121. T.K. Desai, K. Krishnan, N. Samala The incidence of oesophageal adenocarcinoma in non-dysplastic Barrett's oesophagus: a meta-analysis Gut 2011 Oct 13 [Epub ahead of print]
122. P.J.F. De Jonge, M. van Blankenstein, C.W.N. Looman Risk of malignant progression in patients with Barrett's oesophagus: a Dutch nationwide cohort study Gut 59 2010 1030 1036
123. F. Hvid-Jensen, L. Pedersen, A.M. Drewes Incidence of adenocarcinoma among patients with Barrett's esophagus N Engl J Med 365 2011 1375 1383
124. S. Bhat, H. Coleman, F. Yousef Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study J Nat Cancer Inst 103 2011 1049 1057